218

Bioinformatics of the Brain

[49] M. K. Sakharkar, S. K. K. Singh, K. Rajamanickam, et al., “A systems

biology approach towards the identification of candidate therapeutic

genes and potential biomarkers for parkinson’s disease,” PLoS ONE,

vol. 14, 2019.

[50] Y. Miki, S. Shimoyama, T. Kon, et al., “Alteration of autophagy-related

proteins in peripheral blood mononuclear cells of patients with parkin-

son’s disease,” Neurobiology of Aging, vol. 63, pp. 33–43, 2018.

[51] Z. Zhou, S. Zhong, R. Zhang, et al., “Functional analysis of brain derived

neurotrophic factor (bdnf) in huntington’s disease,” Aging (Albany NY),

vol. 13, pp. 6103–6114, 2021.

[52] E. Marfil-Marín, M. Santamaría-Olmedo, A. PerezGrovas-Saltijeral,

et al., “circrna regulates dopaminergic synapse, mapk, and long-term

depression pathways in huntington disease,” Molecular Neurobiology,

vol. 58, pp. 6222–6231, 2021.

[53] W. van Rheenen, F. P. Diekstra, O. Harschnitz, H.-J. Westeneng, et al.,

“Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A

biomarker study,” PLoS ONE, vol. 13, 2018.

[54] W. R. Swindell, C. Kruse, E. O. List, et al., “Als blood expression

profiling identifies new biomarkers, patient subgroups, and evidence for

neutrophilia and hypoxia,” Journal of Translational Medicine, vol. 17,

2019.

[55] H. Li, H. Wu, W. Li, et al., “Constructing a multiple sclerosis diagnosis

model based on microarray,” Frontiers in Neurology, vol. 12, 2022.

[56] E. Lin and S.-J. Tsai, “Genome-wide microarray analysis of gene

expression profiling in major depression and antidepressant ther-

apy,” Progress in Neuro-Psychopharmacology and Biological Psychiatry,

vol. 64, pp. 334–340, 2016.

[57] S. qian Yu, G. Wang, B. Yao, et al., “Arc and homer1 are involved in

comorbid epilepsy and depression: A microarray data analysis,” Epilepsy

& Behavior, vol. 132, 2022.

[58] J. Feng, Q. Zhou, W. Gao, Y. Wu, et al., “Seeking for potential

pathogenic genes of major depressive disorder in the gene expression

omnibus database,” Asia‐Pacific Psychiatry, vol. 12, 2019.

[59] V. V. Wagh, P. Vyas, S. Agrawal, et al., “Peripheral blood-based gene

expression studies in schizophrenia: A systematic review,” Frontiers in

Genetics, vol. 12, 2021.

[60] J. quan Wang, Y. ru Liu, Y. Gao, J. Liang, et al., “Comprehensive bioin-

formatics analysis and molecular validation of lncrnas-mediated cernas

network in schizophrenia,” Life sciences, p. 121205, 2022.